Literature DB >> 18584928

Assessment of synovial vascularization by power Doppler ultrasonography in TMJ internal derangements treated arthroscopically.

Altan Varol1, Selçuk Basa, Asli Topsakal, Ihsan Akpinar.   

Abstract

Our aim was to evaluate the effect of arthroscopic lysis and lavage of the temporomandibular joint (TMJ) on synovial microvascularisation by comparing preoperative and postoperative grades measured by power Doppler ultrasonography (US). We studied 22 patients with hypomobility, clicking, and pain in the TMJ. Power Doppler US were obtained preoperatively to assess the presence of synovial microvascularisation, and arthroscopic lysis and lavage were done after conservative treatment had proved unsuccessful. The severity of synovitis was assessed arthroscopically. The postoperative power Doppler US scans were obtained 2 months later. Other arthroscopic variables were roofing, adhesions, chondromalacia, clicking, and pain. Arthroscopic synovitis with varying degrees of synovial vascularisation was detected in all patients. Pain scores decreased considerably during the postoperative period. We conclude that power Doppler US is a good technique for the assessment of synovial changes by microvascularisation. Arthroscopy of the TMJ reduces synovial vascularisation.

Entities:  

Mesh:

Year:  2008        PMID: 18584928     DOI: 10.1016/j.bjoms.2008.04.022

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  2 in total

Review 1.  The Role of Ultrasound in Temporomandibular Joint Disorders: An Update and Future Perspectives.

Authors:  Beatrice Maranini; Giovanni Ciancio; Stefano Mandrioli; Manlio Galiè; Marcello Govoni
Journal:  Front Med (Lausanne)       Date:  2022-06-20

2.  Dickkopf‑related protein 1 induces angiogenesis by upregulating vascular endothelial growth factor in the synovial fibroblasts of patients with temporomandibular joint disorders.

Authors:  Sheng-Jun Jiang; Wei Li; Ying-Jie Li; Wei Fang; Xing Long
Journal:  Mol Med Rep       Date:  2015-07-20       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.